Last updated on April 2019

Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Ulcerative Colitis


Brief description of study

The primary objective of this study is to evaluate the testicular safety of filgotinib in adult males with moderately to severely active ulcerative colitis.

Clinical Study Identifier: NCT03201445

Contact Investigators or Research Sites near you

Start Over

Avail Clinical Research, LLC

Orange City, FL United States
  Connect »

Nirvana Research Center

Doral, FL United States
  Connect »

Florida Research Institute

Lakewood Ranch, FL United States
  Connect »

Medical Research Center

Miami, FL United States
  Connect »

Tampa General Hospital

Tampa, FL United States
  Connect »

Florida Medical Clinic, PA

Zephyrhills, FL United States
  Connect »

Delta Research Partners

Monroe, LA United States
  Connect »

Louisiana Research Center

Shreveport, LA United States
  Connect »

Gastro Center of Maryland

Columbia, MD United States
  Connect »

Dayton Gastroenterology, Inc

Beavercreek, OH United States
  Connect »

Gastro One

Germantown, TN United States
  Connect »

Spring Gastroenterology

Spring, TX United States
  Connect »

Val R. Hansen, M.D.

Bountiful, UT United States
  Connect »

McGuire DVAMC

Richmond, VA United States
  Connect »

University of Florida

Gainesville, FL United States
  Connect »

The Methodist Hospital

Houston, TX United States
  Connect »

Naval Medical Center San Diego

San Diego, CA United States
  Connect »

Wellington Hospital

Newtown, New Zealand
  Connect »

DHAT Research Institute

Richardson, TX United States
  Connect »

Pinnacle Clinical Research

Live Oak, TX United States
  Connect »

Gandhi Hospital

Secunderabad, India
  Connect »

Clearview Medical Research, LLC

Santa Clarita, CA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.